SK282841B6 - Derivát 4-(1-piperazinyl)benzoovej kyseliny, spôsob jeho prípravy a jeho farmaceutický prostriedok, ktorý ho obsahuje - Google Patents

Derivát 4-(1-piperazinyl)benzoovej kyseliny, spôsob jeho prípravy a jeho farmaceutický prostriedok, ktorý ho obsahuje Download PDF

Info

Publication number
SK282841B6
SK282841B6 SK785-99A SK78599A SK282841B6 SK 282841 B6 SK282841 B6 SK 282841B6 SK 78599 A SK78599 A SK 78599A SK 282841 B6 SK282841 B6 SK 282841B6
Authority
SK
Slovakia
Prior art keywords
formula
piperazinyl
benzoic acid
compound
defined above
Prior art date
Application number
SK785-99A
Other languages
English (en)
Slovak (sk)
Other versions
SK78599A3 (en
Inventor
Grard Moinet
G�Rard Botton
Liliane Doare
Micheline Kergoat
Didier Mesangeau
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of SK78599A3 publication Critical patent/SK78599A3/sk
Publication of SK282841B6 publication Critical patent/SK282841B6/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/04Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
    • C07D215/08Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms with acylated ring nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
SK785-99A 1996-12-18 1997-12-15 Derivát 4-(1-piperazinyl)benzoovej kyseliny, spôsob jeho prípravy a jeho farmaceutický prostriedok, ktorý ho obsahuje SK282841B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9615588A FR2757158B1 (fr) 1996-12-18 1996-12-18 Nouveaux derives d'acide 4-(1-piperazinyl) benzoique, leur procede de preparation et leurs applications therapeutiques
PCT/EP1997/007046 WO1998027078A1 (en) 1996-12-18 1997-12-15 New 4-(1-piperazinyl)benzoic acid derivatives, process for preparing them and their therapeutic applications

Publications (2)

Publication Number Publication Date
SK78599A3 SK78599A3 (en) 2000-03-13
SK282841B6 true SK282841B6 (sk) 2002-12-03

Family

ID=9498818

Family Applications (1)

Application Number Title Priority Date Filing Date
SK785-99A SK282841B6 (sk) 1996-12-18 1997-12-15 Derivát 4-(1-piperazinyl)benzoovej kyseliny, spôsob jeho prípravy a jeho farmaceutický prostriedok, ktorý ho obsahuje

Country Status (26)

Country Link
US (1) US6281215B1 (da)
EP (1) EP0937054B1 (da)
JP (1) JP2001506645A (da)
KR (1) KR20000069544A (da)
CN (1) CN1073102C (da)
AR (1) AR013889A1 (da)
AT (1) ATE218558T1 (da)
AU (1) AU726640B2 (da)
BR (1) BR9713587A (da)
CA (1) CA2275346A1 (da)
CZ (1) CZ218999A3 (da)
DE (1) DE69713128T2 (da)
DK (1) DK0937054T3 (da)
ES (1) ES2178039T3 (da)
FR (1) FR2757158B1 (da)
HU (1) HUP0000586A3 (da)
ID (1) ID23671A (da)
NO (1) NO312896B1 (da)
PL (1) PL334187A1 (da)
PT (1) PT937054E (da)
RU (1) RU2178786C2 (da)
SK (1) SK282841B6 (da)
TR (1) TR199901367T2 (da)
UA (1) UA56206C2 (da)
WO (1) WO1998027078A1 (da)
ZA (1) ZA9711329B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2763334A1 (fr) * 1997-05-13 1998-11-20 Lipha Derives anthraniliques
GB0013346D0 (en) * 2000-06-01 2000-07-26 Glaxo Group Ltd Therapeutic benzamide derivatives
US6476046B1 (en) 2000-12-04 2002-11-05 Sepracor, Inc. Diazabicyclo[4.3.0]nonanes, and methods of use thereof
CN101417988B (zh) * 2007-10-24 2011-04-27 山东轩竹医药科技有限公司 双胍哌嗪类二肽酰肽酶ⅳ抑制剂
CN101781273B (zh) * 2009-01-21 2012-07-04 山东轩竹医药科技有限公司 含有胍基的二肽酰肽酶ⅳ抑制剂

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2346011A1 (fr) * 1976-02-02 1977-10-28 Orsymonde Acetanilido-piperazines
DE3139970A1 (de) * 1981-10-08 1983-04-28 Boehringer Mannheim Gmbh, 6800 Mannheim Neue carbonsaeurederivate, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel
US5364849A (en) * 1989-04-22 1994-11-15 John Wyeth & Brother, Limited 1-[3 or 4-[1-[4-piperazinyl]]-2 arylpropionyl or butryl]-heterocyclic derivatives
FR2693722B1 (fr) 1992-07-16 1994-10-14 Meram Lab Dérivés de la N-cycloalkylpipérazine, procédé d'obtention et compositions pharmaceutiques les contenant.
GB9221931D0 (en) * 1992-10-17 1992-12-02 Wyeth John & Brother Ltd Piperazine derivatives
FR2707984B1 (fr) * 1993-07-23 1995-09-01 Adir Nouvelles pipérazines substituées, leur procédé de préparation et les compositions les contenant.
IT1278960B1 (it) * 1995-02-24 1997-12-02 Elitas S N C Di Belluzzi Lino Macchina tamponatrice per impregnare superficialmente pelli o simili.
US5723475A (en) * 1995-02-28 1998-03-03 Suntory Limited Arylpiperidine and arylpiperazine derivatives and medicament containing the same

Also Published As

Publication number Publication date
NO992968D0 (no) 1999-06-17
EP0937054A1 (en) 1999-08-25
PT937054E (pt) 2002-11-29
DE69713128D1 (de) 2002-07-11
ES2178039T3 (es) 2002-12-16
US6281215B1 (en) 2001-08-28
TR199901367T2 (xx) 1999-10-21
AU726640B2 (en) 2000-11-16
EP0937054B1 (en) 2002-06-05
BR9713587A (pt) 2000-04-04
CA2275346A1 (en) 1998-06-25
NO312896B1 (no) 2002-07-15
AU5758298A (en) 1998-07-15
ATE218558T1 (de) 2002-06-15
FR2757158B1 (fr) 1999-04-02
FR2757158A1 (fr) 1998-06-19
RU2178786C2 (ru) 2002-01-27
KR20000069544A (ko) 2000-11-25
DK0937054T3 (da) 2002-09-16
DE69713128T2 (de) 2003-03-20
UA56206C2 (uk) 2003-05-15
AR013889A1 (es) 2001-01-31
HUP0000586A2 (hu) 2001-04-28
WO1998027078A1 (en) 1998-06-25
ZA9711329B (en) 1998-06-24
HUP0000586A3 (en) 2002-10-28
ID23671A (id) 2000-05-11
PL334187A1 (en) 2000-02-14
JP2001506645A (ja) 2001-05-22
CN1073102C (zh) 2001-10-17
SK78599A3 (en) 2000-03-13
NO992968L (no) 1999-08-17
CZ218999A3 (cs) 1999-09-15
CN1245494A (zh) 2000-02-23

Similar Documents

Publication Publication Date Title
SU1544186A3 (ru) Способ получени амидов
FR2722788A1 (fr) Nouvelles piperazides derivees d'aryl piperazine, leurs procedes de preparation, leur utilisation a titre de medicament et les compositions pharmaceutiques les comprenant
FI93832C (fi) Menetelmä terapeuttisesti aktiivisten piperatsiniijohdannaisten valmistamiseksi
SK1142003A3 (en) Carboxamide compounds and their use as antagonists of a human 11CBY receptor
US6414001B2 (en) Ether and amide compounds preparation thereof composition containing same and use thereof as antidiadetics
NZ281824A (en) N-(arylpiperazinoethyl) naphthalene-2-carboxamides; medicaments
DE69104041T2 (de) Orthosubstituierte biphenylguanidinderivate sowie diese enthaltende antidiabetische oder hypoglykämische mittel.
SU841587A3 (ru) Способ получени производныхАлКилЕНдиАМиНА или иХ КиСлОТНО-АддиТиВНыХ СОлЕй
SK282841B6 (sk) Derivát 4-(1-piperazinyl)benzoovej kyseliny, spôsob jeho prípravy a jeho farmaceutický prostriedok, ktorý ho obsahuje
US4840967A (en) Carbamate or urea derivatives, their preparation and pharmaceutical compositions comprising them
CZ280337B6 (cs) Estery kyseliny dusičné s deriváty cyklohexanolu
CS241064B2 (en) Method of n-substituted nicotinamide's 1-oxide and its salts production
HU192994B (en) Process for preparing 4-/3-alkynyl-oxy-2-hydroxy-propyl/-piperazin-1-y1-n-phenyl-acetamide derivatives
US4176187A (en) Substituted dihydropyridine ureas
CA1085855A (en) N-piperid-4-yl benzamide compounds
US5424312A (en) Aminoalkyl-substituted 2-amino-1,3,4-thiadiazoles, the preparation and use thereof
PL153857B1 (en) Procedure for the production of new derivatives of alkanolamine
HU199792B (en) Process for producing new indolecarboxamide derivatives and pharmaceutical compositions comprising such compounds
US4259327A (en) Substituted aminoalkoxypyridines, compositions and use thereof
JPS5984866A (ja) N−置換ニコチン酸アミド,その塩,それらの製造方法およびそれらを含む医薬
US4474781A (en) Treating hypertension with aminoalkoxypyridines
MXPA99005777A (en) New 4-(1-piperazinyl)benzoic acid derivatives, process for preparing them and their therapeutic applications
RU2198881C2 (ru) α-(1-ПИПЕРАЗИНИЛ)АЦЕТАМИДОПРОИЗВОДНЫЕ АРЕНКАРБОНОВОЙ КИСЛОТЫ, СПОСОБ ИХ ПОЛУЧЕНИЯ, ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СПОСОБЫ ЛЕЧЕНИЯ
KR840002235B1 (ko) 2-아미노-벤조산 유도체의 제조방법
NZ202780A (en) N,n-disubstituted alkenamides and phenylalkenamides and pharmaceutical compositions